25021-207 : Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution
NDC: | 25021-207 |
Labeler: | Sagent Pharmaceuticals |
Product Type: | Human Prescription Drug |
Drug Name: | Doxorubicin Hydrochloride |
Dosage Form: | Intravenous Injection, Solution |
Application #: | ANDA091495 |
Rev. Date: |
NDC Package Codes:
- 25021-207-05: 10 VIAL IN 1 CARTON (25021‑207‑05) > 5 ML IN 1 VIAL
- 25021-207-25: 1 VIAL IN 1 CARTON (25021‑207‑25) > 25 ML IN 1 VIAL
- 25021-207-51: 1 VIAL IN 1 CARTON (25021‑207‑51) > 100 ML IN 1 VIAL
Active Ingredients:
- Doxorubicin Hydrochloride
Dosage Strength:
- 2 mg/mL
Pharmaceutical Classes:
- Anthracycline Topoisomerase Inhibitor [EPC]
- Anthracyclines [Chemical/Ingredient]
- Topoisomerase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0069-0170 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc.
- 0069-0171 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc.
- 0069-1542 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0069-3030 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0069-3031 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0069-3032 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0069-3033 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0069-3034 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0069-4004 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0069-4015 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0069-4026 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0069-4030 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0069-4031 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0069-4032 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0069-4033 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0069-4034 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0069-4037 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc
- 0143-9084 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
- 0143-9085 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
- 0143-9086 Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hikma Pharmaceuticals USA Inc.
- More related products ...
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 25021-206Next: 25021-208 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.